Randomized Clinical Trial of Thrice-Weekly 4-Month Moxifloxacin or Gatifloxacin Containing Regimens in the Treatment of New Sputum Positive Pulmonary Tuberculosis Patients

Doherty, T. Mark and Jawahar, Mohideen S. and Banurekha, Vaithilingam V. and Paramasivan, Chinnampedu N. and Rahman, Fathima and Ramachandran, Rajeswari and Venkatesan, Perumal and Balasubramanian, Rani and Selvakumar, Nagamiah and Ponnuraja, Chinnaiyan and Iliayas, Allaudeen S. and Gangadevi, Navaneethapandian P. and Raman, Balambal and Baskaran, Dhanaraj and Kumar, Santhanakrishnan R. and Kumar, Marimuthu M. and Mohan, Victor and Ganapathy, Sudha and Kumar, Vanaja and Shanmugam, Geetha and Charles, Niruparani and Sakthivel, Murugesan R. and Jagannath, Kannivelu and Chandrasekar, Chockalingam and Parthasarathy, Ramavaram T. and Narayanan, Paranji R. (2013) Randomized Clinical Trial of Thrice-Weekly 4-Month Moxifloxacin or Gatifloxacin Containing Regimens in the Treatment of New Sputum Positive Pulmonary Tuberculosis Patients. PLoS ONE, 8 (7). e67030. ISSN 1932-6203

Archive 201336.pdf - Published Version Download (657kB)

Affiliation:	ICMR-National Institute for Research in Tuberculosis
Item Type:	Article
Uncontrolled Keywords:	Randomized Clinical Trial, Thrice-Weekly 4-Month Moxifloxacin or Gatifloxacin, Sputum Positive, Pulmonary Tuberculosis
Subjects:	Tuberculosis > Clinical Research Tuberculosis > Operational Research
Divisions:	Clinical Research
Depositing User:	Dr. Rathinasabapati R
Date Deposited:	19 Sep 2022 11:36
Last Modified:	19 Sep 2022 11:36
URI:	http://eprints.nirt.res.in/id/eprint/1239

Actions (login required)

View Item